Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PTSD Prevention Using Oral Hydrocortisone in the Immediate Aftermath of Trauma

NCT04924166 is registered in ClinicalTrials.gov with Rachel Yehuda as lead sponsor.

NCT NCT04924166
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04924166 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PTSD Prevention Using Oral Hydrocortisone in the Immediate Aftermath of Trauma
Lead sponsor
Rachel Yehuda
Phase
Phase 2
Overall status
Completed
Start date
January 12, 2022
Completion date
July 6, 2025
Enrollment
201 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute stress disorder, ptsd, trauma-related stressor